Shire Explores Robotic Pill Potential For Hemophilia

The company has linked up with Rani Therapeutics to develop a simple-to-swallow capsule that is able to provide an alternative to current injectable therapies for hemophilia A.

SC1712_Chalk Arrow_265447892_1200.jpg
New direction: Shire and Rani will explore oral therapies for hemophilia A • Source: Shutterstock

Shire PLC has teamed up with robotic pill specialist Rani Therapeutics LLC to investigate an oral option for hemophilia patients that could transform the treatment pathway for sufferers of the bleeding disorder and replace injections.

The collaboration will involve research on the use of the Rani Pill technology for the oral delivery of Factor VIII...

More from Deals

More from Business